I'm LongbridgeAI, I can summarize articles.The Week
Tenet Healthcare (THC) closed the week up 0.95% at $286.03, underperforming the S&P 500’s 2.51% gain by roughly 1.56 percentage points. Price action was choppy: shares pushed higher from Monday through Wednesday, then pulled back on Thursday and Friday, touching a weekly low of $282.44 on Friday. The full-week range was 4.56%. No major catalysts emerged during the week.
Analyst Ratings
Of the 23 institutions covering the stock, 14 rate it buy, 5 rate it outperform, and 4 rate it hold, with no underperform or sell ratings. The consensus rating is buy, and the consensus target of $307.32 sits about 7.4% above the last close. Targets range from $265 to $342, reflecting a fairly wide spread. The stock ranks 2nd among 20 companies in its industry group.
The Week Ahead
The coming week brings a run of US macro data: the New York Fed manufacturing index on 16 November, followed by retail sales, industrial production, and the NAHB housing market index on 17 November. Tenet Healthcare has no earnings scheduled for next week; its FY2026 annual results are set for 9 February 2027, after the close.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
